Kofax® Limited (NASDAQ:KFX) LSE:KFX), a leading provider of smart
process applications for the business critical First Mile™ of customer
interactions, today announced that Kofax Mobile Capture™ Platform
received the 2014 Software of the Year Award from Document
Manager (DM) Magazine at the Hotel Russell in London’s Russell Square.
First Ebola Vaccine Candidate based on the 2014 Guinea Ebola Strain Genetic Sequence Robust immune responses demonstrated in preclinical studies; exceptional responses when used with Novavax' Matrix-M™ adjuvant Non-human primate study initiated GMP manufacture initiated; Scaled-up manufacturing to begin 1 st quarter 2015 Phase 1 clinical trial anticipated to start in December 2014
GAITHERSBURG, Md., Oct.
- HETLIOZ® U.S. sales grew to $5.2 million in the first full quarter since launch - HETLIOZAccess™ Named Patient Program launched in Europe and Canada
- Fanapt® generated first ex-U.S. product revenue WASHINGTON , Oct.
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company
focused on delivering innovative therapies to patients with kidney
disease through the biology of hypoxia inducible factor (HIF), today
announced positive top-line results from its Phase 2b placebo-controlled
trial of AKB-6548 in non-dialysis patients with anemia related to
chronic kidney disease (CKD). The study achieved its primary endpoint
and AKB-6548 was generally well tolerated, confirming that the
once-daily, oral therapy can successfully increase and maintain
hemoglobin (HGB) levels.
Move in recognition of Singapore's growing status as a global centre of excellence for FX trading Company believes Singapore will continue to grow in dominance in the Asia-Pacific FX space over the next five years
SINGAPORE , Oct.
- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - - Acquisition Eliminates Potential $209 Million in Future Developmental and Sales Milestone Payments by CTI Under Prior Agreement with Chroma -
SEATTLE , Oct.
By Sue Chang, MarketWatch
SAN FRANCISCO (MarketWatch)--Among the companies whose shares are expected to see active trading in Monday's session are Twitter Inc., Merck & Co., and Allergan Inc.
Twitter(TWTR) is projected to report third-quarter earnings of a penny a share, according to a consensus survey by FactSet.
By Wallace Witkowski, MarketWatch
SAN FRANCISCO (MarketWatch)--Earnings from the energy and health care sectors will dominate investor attention as respective heavyweights report following a week where upside earnings surprises lifted the broader market out of a slump.
- ICL's Performance Products segment to divest its Germany-based APW business as part of ICL's strategy to focus on its core businesses in agriculture, food and engineered materials -
TOKYO and TEL AVIV, Israel , Oct.
Sciences Corporation (NYSE:ORB), one of the world’s leading space
technology companies, today announced that it is prepared to launch the
company’s Antares TM
rocket carrying a Cygnus TM
cargo logistics spacecraft destined for the International Space Station
(ISS) under the Commercial Resupply Services (CRS) contract with NASA.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.